Request Processed
Your registration request has been processed. We will contact you soon.
Register
First name
Last name
Email
Company
Toggle navigation
Toggle navigation
Login
Register
About
Contact Us
1
2
3
4
5
…
Next ›
Last »
Prevision Policy Clips | FDA Commissioner Hahn In Self-Isolation After Possible COVID-19 Exposure
May 11, 2020
Exit Interview With Joe Grogan: “Deal To Be Had” On Part D Redesign Before The Election; White House DPC Will Shift To Campaign Mode
May 9, 2020
Prevision Policy Clips | ACTIV Update: COVID-19 Partnership Has 170 Therapeutic Candidates Under Review
May 8, 2020
Prevision Policy Clips | Trump Administration Health Policy Leadership Shifts Back To HHS
May 7, 2020
Generic Drug Group Pushing For “American Allies” Supply Chain; Blueprint Calls For FDA Role To Relocate, Refurbish Plants
May 6, 2020
Remdesivir Emergency Use Authorization: Two Ways To Think About Government Drug Distribution
May 6, 2020
Prevision Policy Clips | FDA Commissioner Hahn, NIAID Director Fauci To Testify At Senate HELP Hearing May 12
May 6, 2020
Oncology FDA Approvals Ahead Of Schedule, Launched Into Challenging Environment; Oral Drugs Fare Better In A Disruptive Climate
May 5, 2020
Re-Opening FDA: Early Thoughts On The “New Normal”
May 5, 2020
Prevision Policy Clips | Regeneron's Coronavirus Antibody Treatment On Track For June Trials
May 5, 2020
Rx Vial Size: FDA Defends Safety First Approach As NASEM Starts Work On Proposals To Reduce “Wastage” Of High Cost Drugs
May 4, 2020
CMS COVID-19 Interim Rule Expands Coverage Of Drug Administration To Temporary Outpatient Hospital Locations – Including Patient Homes
May 4, 2020
Prevision Policy Clips | Gilead Remdesivir Emergency Use Authorization Uses Federally-Managed Restricted Distribution Plan
May 4, 2020
Tracing And Wholesale Distribution Requirements Lifted For COVID-19 Products Under Temporary FDA Policy; Remdesivir Would Be Covered
May 1, 2020
CDER Details Three-Step Safety Signal Evaluation Process, Sets Rules For How FDA Will Handle Signals; Transition To New System Comes Amid Workplace Disruption
May 1, 2020
Prevision Policy Clips | Gilead Remdesivir At FDA: Company Expects “Two Step” Approval Process
May 1, 2020
Prevision Policy Clips | White House Advisor Grogan To Leave Administration In May
April 30, 2020
Cures II “Concept Paper” Proposes Formal Role For Real-World Evidence In Breakthrough Therapy, Accelerated Approval Decisions
April 29, 2020
COVID-19 Vaccines: Experience From Ebola, Previous Production Expansions Suggest Tough Challenges Ahead; Danger Of “Over-Promising”?
April 29, 2020
Prevision Policy Clips | FDA Approves Less-Frequent Dosing For Merck’s Keytruda Amid COVID-19 Disruptions
April 29, 2020
Advisory Committee Tracker: Preparing For Virtual Reality – Which Sponsor Will Go First?
April 28, 2020
Prevision Policy Clips | FDA Data Strategy Public Meeting Rescheduled For June 30
April 28, 2020
Prevision Policy Clips | HHS Secretary Azar Not Being Fired, President Trump Tweets
April 27, 2020
Rare Disease Clinical Trial Issues Heightened By COVID But Potential Exists for Long-Term Improvements With Remote Monitoring As CMS Loosens Some Technical Restrictions, Advocates Say
April 24, 2020
Prevision Policy Clips | HHS Infighting Casts Large Shadow Over COVID-19 Response
April 24, 2020
1
2
3
4
5
…
Next ›
Last »